WHAT DOES IT MEAN TO ME? The Digital Pathology Association 2016 Webinar Series – Session 2 Available to Members Only Thursday, May 25, 2016 | 1pm EST Learn more about the newly released FDA Guidance for Technical Performance Assessment of...

The featured post for today is guest written by Dr. Anil Parwani, known throughout the industry as a key opinion leader and has been very active in digital pathology among many other professional and research interests. In his post he looks...

The DPA, offers a scholarship intended to support the advancement of knowledge and continuing education in digital pathology. It is presented to a National Society for Histotechnology (NSH) member certified in histology, and currently...

The Digital Pathology Association (DPA) recently announced its suggestion that digital pathology manufacturers currently interested in marketing Whole Slide Imaging (WSI) devices for primary diagnosis in the United States submit de novo...

Last week news was released after months of speculation, that the FDA would consider the de novo classification option for digital pathology systems as a pathway for bringing to market a moderate or low risk device which has not yet been...

Collaboration with FDA Results in Opportunity for Streamlined Approval Process The Digital Pathology Association (DPA) announced today that it suggests digital pathology manufacturers currently interested in marketing whole slide imaging (WSI)...